Union Health Minister Launches India's
First National "Lung Cancer Treatment and Palliative Care: Evidence-Based
Guidelines" in New Delhi
Ahead of World Cancer Day 2026, the Union Health
Minister launched India's first national "Lung Cancer Treatment and
Palliative Care: Evidence-Based Guidelines" in New Delhi, a significant
step towards standardized lung cancer care. Developed by national oncology
experts under the Department of Health Research (DHR) and the Directorate
General of Health Services (DGHS), the guidelines aim to provide a
standardized, evidence-based framework for diagnosis, treatment, and palliative
care. These are designed to ensure high-quality, accessible, and
patient-centered care.
Key Features of the Guidelines
¨
The guidelines include 15
evidence-based recommendations addressing both lung cancer treatment and
palliative care.
¨
The recommendations are
based on systematic evidence synthesis and are adapted to Indian healthcare
realities.
¨
The guidelines aim to
reduce variations in clinical practices across public and private healthcare
systems.
¨
These guidelines have
been made publicly accessible through the Department of Health Research
website, enhancing transparency and facilitating their adoption.
Summary of 15 Evidence-Based
Recommendations
¨
Rehabilitation is
recommended for patients undergoing lung cancer surgery.
¨
Mediastinal lymph node
dissection is recommended over mediastinal lymph node sampling in operable lung
cancer.
¨
In patients with
oligometastatic disease, radical local treatment of both primary and metastatic
sites is advised instead of systemic therapy alone.
¨
Prophylactic cranial
irradiation (PCI) is recommended for patients with small cell lung cancer.
¨
For patients with
limited-stage small cell lung cancer, early or late integration of thoracic
radiotherapy with chemotherapy is recommended.
¨
Routine use of
postoperative radiotherapy after complete surgical resection is not
recommended.
¨
Stereotactic body
radiation therapy (SBRT) is not recommended over lobectomy or segmentectomy,
except for selected patients who are medically unfit or unwilling to undergo
surgery.
¨
Adjuvant tyrosine kinase
inhibitor (TKI) therapy is recommended over chemotherapy alone in eligible
patients.
¨
Second- and
third-generation tyrosine kinase inhibitors are recommended over
first-generation TKIs in appropriate clinical settings.
¨
Immunotherapy, alone or
in combination with other agents, is considered superior to chemotherapy alone
in suitable patients.
¨
Based on clinical
judgment and patient factors, either neoadjuvant therapy followed by surgery or
surgery followed by adjuvant therapy is advised.
¨
Low-dose pembrolizumab
(100 mg) may be advised on an individual basis when the standard dose is not
feasible.
¨
Early integration of
palliative care with standard oncological care is recommended for lung cancer
patients compared to standard oncological care alone.
¨
Multimodal treatment is
recommended for the management of dyspnea in patients with advanced lung cancer
compared to pharmacotherapy alone.
¨
A multimodal approach to
treatment is recommended for lung cancer patients instead of psychotherapeutic
care alone.
Importance for the Indian Healthcare
System
¨
The guidelines make early
diagnosis accessible and pave the way for uniform treatment for lung cancer
patients.
¨
The emphasis on
palliative care facilitates holistic and patient-centered management,
especially in advanced stage cases.
¨ The framework promotes reliability, consistency, and evidence-based clinical decision-making.
¨ This initiative reflects India's transition towards indigenous, context-specific healthcare solutions rather than blindly imitating global models.
